Open -label, 6-12 months Safety and Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Subjects with Advanced Parkinson's Disease and Severe Motor-Fluctuations, Protocol# S187.3.004

Grants and Contracts Details

StatusFinished
Effective start/end date4/16/096/30/14

Funding

  • Quintiles Inc: $265,461.00